Want to create an interactive transcript for this episode?
Podcast: OncLive® On Air
Episode: Bhatnagar Spotlights Ongoing Uproleselan Investigations in AML
Description: Dr Bhatnagar discusses the prior and ongoing studies evaluating the addition of uproleselan to standard-of-care regimens for patients with AML, why uproleselan could affect the treatment paradigm across AML subtypes, and the rationale for pursuing minimal residual disease negativity as a clinical end point in AML.